Telehealth program to improve vaccine uptake in Southeastern Louisiana
Official title: Using a Telehealth and Shared Decision-Making Model to Address Preventative Medicine Strategies Among Communities in Louisiana
Run by Xavier University of Louisiana. · NCT05676970 · Data updated 2026-11-12
This study is testing a telehealth program that combines wellness education with vaccination counseling to see if it can help people in Southeastern Louisiana, especially those in high-risk groups, get more COVID-19 and flu vaccines.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Xavier University of Louisiana. Academic / other |
| Locations | 1 site (New Orleans, Louisiana) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 1, 2028 |
| Study ends | December 30, 2028 |
| Registry record updated | March 3, 2026 |
| Trial ID | NCT05676970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 who are currently employed or seeking training in high-risk industries and have incomplete vaccination status.
✕Probably not a fit
Patients who have already completed their COVID-19 vaccinations or have documented allergies to the vaccines may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This intervention focuses on addressing vaccine hesitancy through a telehealth model that combines wellness education with vaccination counseling. Over a period of 24-30 months, individuals will be randomized into two groups: one receiving wellness education only and the other receiving additional vaccination education. The study aims to recruit 525 participants from high-risk industries, particularly targeting African-American and Hispanic individuals from semi-rural or rural communities. The primary goal is to increase completion rates of COVID-19 vaccinations, while also monitoring influenza vaccine uptake.
Why it matters
Potential benefit: If successful, this program could significantly increase vaccination rates among vulnerable populations, thereby improving public health outcomes.
How similar studies have gone: While there have been studies addressing vaccine hesitancy, this specific telehealth approach targeting high-risk industries and social determinants of health is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 years to 55 years of age 2. Able to speak English 3. Currently employed or seeking training in target industries such as: healthcare, education, beauty, hospitality, food (culinary) and industrial plant workers. 4. Able to use Telehealth technology via tablet, cell phone, or computer Exclusion Criteria: 1\. Individuals who are unable to give informed consent.
Where it's running
-
Xavier University of Louisiana
New Orleans, Louisiana, United States Recruiting
Study contacts
- Principal investigator: Sara Al-Dahir, PhD — Xavier University of Louisiana.
- Study coordinator: Sara Al-Dahir, PharmD, PhD
- Email: saaldah@xula.edu
- Phone: 5045205766
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.